Cardiogenic embolism in the cat
Cardiogenic embolism (CE) in the cat, which has also been referred to as arterial thromboembolism, feline arterial thromboembolism, and saddle thrombus has been identified clinically in cats for decades and is an important clinical development and cause of death in cats with underlying heart disease...
Gespeichert in:
| Veröffentlicht in: | Journal of veterinary cardiology 2015-12, Vol.17, p.S202-S214 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S214 |
|---|---|
| container_issue | |
| container_start_page | S202 |
| container_title | Journal of veterinary cardiology |
| container_volume | 17 |
| creator | Hogan, Daniel F. Brainard, Benjamin M. |
| description | Cardiogenic embolism (CE) in the cat, which has also been referred to as arterial thromboembolism, feline arterial thromboembolism, and saddle thrombus has been identified clinically in cats for decades and is an important clinical development and cause of death in cats with underlying heart disease. While a better understanding of this condition has been developed over the decades it is extremely frustrating to clinicians that there have not been dramatic changes in prevention or outcome. Only recently has the first prospective thromboprophylactic study on CE in cats been completed. While new antithrombotic drugs are developed for humans on a regular basis, it has been challenging to get pharmaceutical companies to focus on the feline species. Additionally, there remains an absence of clinical data to identify cats at risk for developing CE aside from the simple fact that they have underlying heart disease. This review will attempt to present a summary of where we stand in 2015 with regards to clinical presentation, survival, thrombotic risk, and prevention. |
| doi_str_mv | 10.1016/j.jvc.2015.10.006 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760876847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1760273415000971</els_id><sourcerecordid>1760876847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-8dc9842204e0737fc89a64b26ea4cff97d9a0335c4607024b2a13aa9e7d2e8fb3</originalsourceid><addsrcrecordid>eNp9kDtPwzAUhS0EoqXwA1ggI0vCje3YjphQxUuqxAKz5Tg34CqPYqeV-Pc4amFkuq9zj3Q-Qi5zyHLIxe06W-9sRiEv4pwBiCMyz5UsUlCMH8deCkipZHxGzkJYAzBFQZ6SGRVSikKWc3K9NL52wwf2zibYVUPrQpe4Phk_MbFmPCcnjWkDXhzqgrw_Prwtn9PV69PL8n6VWlawMVW1LRWnFDiCZLKxqjSCV1Sg4bZpSlmXBhgrLBcggcaLyZkxJcqaomoqtiA3e9-NH762GEbduWCxbU2PwzboKYqSQnEZpfleav0QgsdGb7zrjP_WOeiJi17ryEVPXKZV5BJ_rg7226rD-u_jF0QU3O0FGEPuHHodrMPeYu082lHXg_vH_geVknDt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760876847</pqid></control><display><type>article</type><title>Cardiogenic embolism in the cat</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hogan, Daniel F. ; Brainard, Benjamin M.</creator><creatorcontrib>Hogan, Daniel F. ; Brainard, Benjamin M.</creatorcontrib><description>Cardiogenic embolism (CE) in the cat, which has also been referred to as arterial thromboembolism, feline arterial thromboembolism, and saddle thrombus has been identified clinically in cats for decades and is an important clinical development and cause of death in cats with underlying heart disease. While a better understanding of this condition has been developed over the decades it is extremely frustrating to clinicians that there have not been dramatic changes in prevention or outcome. Only recently has the first prospective thromboprophylactic study on CE in cats been completed. While new antithrombotic drugs are developed for humans on a regular basis, it has been challenging to get pharmaceutical companies to focus on the feline species. Additionally, there remains an absence of clinical data to identify cats at risk for developing CE aside from the simple fact that they have underlying heart disease. This review will attempt to present a summary of where we stand in 2015 with regards to clinical presentation, survival, thrombotic risk, and prevention.</description><identifier>ISSN: 1760-2734</identifier><identifier>EISSN: 1875-0834</identifier><identifier>DOI: 10.1016/j.jvc.2015.10.006</identifier><identifier>PMID: 26776579</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Anticoagulants - therapeutic use ; Cat Diseases - diagnosis ; Cat Diseases - drug therapy ; Cat Diseases - pathology ; Cats ; Embolism - drug therapy ; Embolism - pathology ; Embolism - veterinary ; Feline ; Fibrinolytic Agents - therapeutic use ; Heart Diseases - drug therapy ; Heart Diseases - pathology ; Infarction ; Stroke ; Thromboprophylaxis ; Thrombosis</subject><ispartof>Journal of veterinary cardiology, 2015-12, Vol.17, p.S202-S214</ispartof><rights>2015 Elsevier B.V.</rights><rights>Copyright © 2015 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-8dc9842204e0737fc89a64b26ea4cff97d9a0335c4607024b2a13aa9e7d2e8fb3</citedby><cites>FETCH-LOGICAL-c353t-8dc9842204e0737fc89a64b26ea4cff97d9a0335c4607024b2a13aa9e7d2e8fb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1760273415000971$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26776579$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hogan, Daniel F.</creatorcontrib><creatorcontrib>Brainard, Benjamin M.</creatorcontrib><title>Cardiogenic embolism in the cat</title><title>Journal of veterinary cardiology</title><addtitle>J Vet Cardiol</addtitle><description>Cardiogenic embolism (CE) in the cat, which has also been referred to as arterial thromboembolism, feline arterial thromboembolism, and saddle thrombus has been identified clinically in cats for decades and is an important clinical development and cause of death in cats with underlying heart disease. While a better understanding of this condition has been developed over the decades it is extremely frustrating to clinicians that there have not been dramatic changes in prevention or outcome. Only recently has the first prospective thromboprophylactic study on CE in cats been completed. While new antithrombotic drugs are developed for humans on a regular basis, it has been challenging to get pharmaceutical companies to focus on the feline species. Additionally, there remains an absence of clinical data to identify cats at risk for developing CE aside from the simple fact that they have underlying heart disease. This review will attempt to present a summary of where we stand in 2015 with regards to clinical presentation, survival, thrombotic risk, and prevention.</description><subject>Animals</subject><subject>Anticoagulants - therapeutic use</subject><subject>Cat Diseases - diagnosis</subject><subject>Cat Diseases - drug therapy</subject><subject>Cat Diseases - pathology</subject><subject>Cats</subject><subject>Embolism - drug therapy</subject><subject>Embolism - pathology</subject><subject>Embolism - veterinary</subject><subject>Feline</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Heart Diseases - drug therapy</subject><subject>Heart Diseases - pathology</subject><subject>Infarction</subject><subject>Stroke</subject><subject>Thromboprophylaxis</subject><subject>Thrombosis</subject><issn>1760-2734</issn><issn>1875-0834</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kDtPwzAUhS0EoqXwA1ggI0vCje3YjphQxUuqxAKz5Tg34CqPYqeV-Pc4amFkuq9zj3Q-Qi5zyHLIxe06W-9sRiEv4pwBiCMyz5UsUlCMH8deCkipZHxGzkJYAzBFQZ6SGRVSikKWc3K9NL52wwf2zibYVUPrQpe4Phk_MbFmPCcnjWkDXhzqgrw_Prwtn9PV69PL8n6VWlawMVW1LRWnFDiCZLKxqjSCV1Sg4bZpSlmXBhgrLBcggcaLyZkxJcqaomoqtiA3e9-NH762GEbduWCxbU2PwzboKYqSQnEZpfleav0QgsdGb7zrjP_WOeiJi17ryEVPXKZV5BJ_rg7226rD-u_jF0QU3O0FGEPuHHodrMPeYu082lHXg_vH_geVknDt</recordid><startdate>201512</startdate><enddate>201512</enddate><creator>Hogan, Daniel F.</creator><creator>Brainard, Benjamin M.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201512</creationdate><title>Cardiogenic embolism in the cat</title><author>Hogan, Daniel F. ; Brainard, Benjamin M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-8dc9842204e0737fc89a64b26ea4cff97d9a0335c4607024b2a13aa9e7d2e8fb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Anticoagulants - therapeutic use</topic><topic>Cat Diseases - diagnosis</topic><topic>Cat Diseases - drug therapy</topic><topic>Cat Diseases - pathology</topic><topic>Cats</topic><topic>Embolism - drug therapy</topic><topic>Embolism - pathology</topic><topic>Embolism - veterinary</topic><topic>Feline</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Heart Diseases - drug therapy</topic><topic>Heart Diseases - pathology</topic><topic>Infarction</topic><topic>Stroke</topic><topic>Thromboprophylaxis</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hogan, Daniel F.</creatorcontrib><creatorcontrib>Brainard, Benjamin M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of veterinary cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hogan, Daniel F.</au><au>Brainard, Benjamin M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiogenic embolism in the cat</atitle><jtitle>Journal of veterinary cardiology</jtitle><addtitle>J Vet Cardiol</addtitle><date>2015-12</date><risdate>2015</risdate><volume>17</volume><spage>S202</spage><epage>S214</epage><pages>S202-S214</pages><issn>1760-2734</issn><eissn>1875-0834</eissn><abstract>Cardiogenic embolism (CE) in the cat, which has also been referred to as arterial thromboembolism, feline arterial thromboembolism, and saddle thrombus has been identified clinically in cats for decades and is an important clinical development and cause of death in cats with underlying heart disease. While a better understanding of this condition has been developed over the decades it is extremely frustrating to clinicians that there have not been dramatic changes in prevention or outcome. Only recently has the first prospective thromboprophylactic study on CE in cats been completed. While new antithrombotic drugs are developed for humans on a regular basis, it has been challenging to get pharmaceutical companies to focus on the feline species. Additionally, there remains an absence of clinical data to identify cats at risk for developing CE aside from the simple fact that they have underlying heart disease. This review will attempt to present a summary of where we stand in 2015 with regards to clinical presentation, survival, thrombotic risk, and prevention.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>26776579</pmid><doi>10.1016/j.jvc.2015.10.006</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1760-2734 |
| ispartof | Journal of veterinary cardiology, 2015-12, Vol.17, p.S202-S214 |
| issn | 1760-2734 1875-0834 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1760876847 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Animals Anticoagulants - therapeutic use Cat Diseases - diagnosis Cat Diseases - drug therapy Cat Diseases - pathology Cats Embolism - drug therapy Embolism - pathology Embolism - veterinary Feline Fibrinolytic Agents - therapeutic use Heart Diseases - drug therapy Heart Diseases - pathology Infarction Stroke Thromboprophylaxis Thrombosis |
| title | Cardiogenic embolism in the cat |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T00%3A21%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiogenic%20embolism%20in%20the%20cat&rft.jtitle=Journal%20of%20veterinary%20cardiology&rft.au=Hogan,%20Daniel%20F.&rft.date=2015-12&rft.volume=17&rft.spage=S202&rft.epage=S214&rft.pages=S202-S214&rft.issn=1760-2734&rft.eissn=1875-0834&rft_id=info:doi/10.1016/j.jvc.2015.10.006&rft_dat=%3Cproquest_cross%3E1760876847%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760876847&rft_id=info:pmid/26776579&rft_els_id=S1760273415000971&rfr_iscdi=true |